Non invasive visualization of biologic and topographic changes in (sub-)cutaneous melanoma metastases induced by antitumoral treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017175

Enrollment

Registered

2019-05-16

Start date

2019-05-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C43.9 C79.2

Interventions

Group 1: (Sub-) cutaneous metastases will be visualized in MSOT before, during and after melanoma treatment. MSOT is a technique that resembles ultrasound. The visualization will be performed regularl

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patients with (sub-)cutaneous melanoma metastases - age =18 years

Exclusion criteria

Exclusion criteria: - age < 18 years - pregnancy

Design outcomes

Primary

Measure	Time frame
Quantification in decrease of optical density (induced by reduction of melanin containing cells) before (, during) and after melanoma Treatment. The optical density (OD) will comparatively be quantified in the MSOT.	—

Secondary

Measure	Time frame
Quantification of vessel density in cutaneous metastasis before (, during) and after melanoma treatment. The number and size of vessels will comparatively be quantified in the MSOT.	—

Countries

Germany

Contacts

Public ContactIngo Stoffels

Universitätsklinikum Essen

ingo.stoffels@uk-essen.de00492014756

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026